HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.

AbstractBACKGROUND:
Newborns and young infants are at higher risk for infections than adults, and manifest suboptimal vaccine responses, motivating a search for novel immunomodulators and/or vaccine adjuvants effective in early life. In contrast to most TLR agonists (TLRA), TLR8 agonists such as imidazoquinolines (IMQs) induce adult-level Th1-polarizing cytokine production from human neonatal cord blood monocytes and are candidate early life adjuvants. We assessed whether TLR8-activating IMQ congeners may differ in potency and efficacy in inducing neonatal cytokine production in vitro, comparing the novel TLR7/8-activating IMQ analogues Hybrid-2, Meta-amine, and Para-amine to the benchmark IMQ resiquimod (R848).
METHODS:
TLRA-induced NF-κB activation was measured in TLR-transfected HEK cells. Cytokine production in human newborn cord and adult peripheral blood and in monocyte-derived dendritic cell cultures were measured by ELISA and multiplex assays. X-ray crystallography characterized the interaction of human TLR8 with Hybrid-2.
RESULTS:
Hybrid-2 selectively activated both TLR7 and 8 and was more potent than R848 in inducing adult-like levels of TNF-α, and IL-1β. Consistent with its relatively high in vitro activity, crystallographic studies suggest that absence in Hybrid-2 of an ether oxygen of the C2-ethoxymethyl substituent, which can engage in unfavorable electrostatic and/or dipolar interactions with the carbonyl oxygen of Gly572 in human TLR8, may confer greater efficacy and potency compared to R848.
CONCLUSIONS:
Hybrid-2 is a selective and potent TLR7/8 agonist that is a candidate adjuvant for early life immunization.
AuthorsLakshmi Ganapathi, Simon Van Haren, David J Dowling, Ilana Bergelson, Nikunj M Shukla, Subbalakshmi S Malladi, Rajalakshmi Balakrishna, Hiromi Tanji, Umeharu Ohto, Toshiyuki Shimizu, Sunil A David, Ofer Levy
JournalPloS one (PLoS One) Vol. 10 Issue 8 Pg. e0134640 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26274907 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Imidazoles
  • Immunosuppressive Agents
  • Quinolines
  • Recombinant Fusion Proteins
  • Toll-Like Receptor 7
  • Toll-Like Receptor 8
  • resiquimod
Topics
  • Adult
  • Cytokines (metabolism)
  • Dendritic Cells (drug effects, metabolism)
  • Female
  • Fetal Blood (cytology, drug effects, metabolism)
  • HEK293 Cells
  • Humans
  • Imidazoles (pharmacology)
  • Immunosuppressive Agents (pharmacology)
  • Infant, Newborn
  • Leukocytes (drug effects, metabolism)
  • Pregnancy
  • Quinolines (pharmacology)
  • Recombinant Fusion Proteins (pharmacology)
  • Toll-Like Receptor 7 (agonists)
  • Toll-Like Receptor 8 (agonists)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: